 MORRISVILLE, N.C., Dec. 10, 2020 GLOBE NEWSWIRE -- Syneos Health Nasdaq:SYNH, the only fully integrated biopharmaceutical solutions organization, today announced that it has completed the previously announced acquisition of Synteract, a leading full-service CRO focused on the rapidly growing, emerging biopharma segment. 